Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Oct 1;351(Pt 1):151–159. doi: 10.1042/0264-6021:3510151

Regulation of the Raf-1 kinase domain by phosphorylation and 14-3-3 association.

M T Yip-Schneider 1, W Miao 1, A Lin 1, D S Barnard 1, G Tzivion 1, M S Marshall 1
PMCID: PMC1221345  PMID: 10998357

Abstract

The Raf-1 kinase domain is kept in an inactive state by the N-terminal regulatory domain. Activation of the kinase domain occurs following release from the N-terminal repression and possible catalytic upregulation. To distinguish the regulatory mechanisms that directly influence the catalytic activity of the enzyme from those which act through the inhibitory domain, the catalytic domain of Raf-1 (CR3) was expressed in COS-7 cells. The role of phosphorylation in the direct regulation of this domain was determined by substituting non-phosphorylatable amino acids for known serine and tyrosine phosphorylation sites. The intrinsic activity of each mutant protein was determined as well as stimulation by v-Src and phorbol esters. Both v-Src and phorbol esters were potent activators of CR3, requiring the serine 338/339 (p21-activated protein kinase, Pak) and tyrosine 340/341 (Src) phosphorylation sites for full stimulation of CR3. In contrast, loss of the serine 497/499 protein kinase C phosphorylation sites had little effect on CR3 activation by either v-Src or phorbol esters. Loss of serine 621, a 14-3-3 adaptor-protein-binding site, prevented activation of CR3 by v-Src or phorbol esters and partially decreased the high basal activity of the kinase fragment. When co-expressed in COS-7 cells, 14-3-3 associated strongly with full-length Raf-1, weakly with wild-type CR3 and not at all with the A621 and D621 CR3 mutants. The role of 14-3-3 in maintaining the activity of the catalytic domain of Raf-1 was investigated further by performing peptide-competition studies with wild-type CR3, wild-type CR3 and v-Src or constitutively active CR3 (CR3[YY340/341DD]). In each case, incubation of the proteins with a phosphoserine-621 Raf-1 peptide, which we show displaced Raf-1 and CR3[YY340/341DD] from 14-3-3, was found to substantially reduce catalytic activity. Taken together, our results support a model of Raf regulation in which the activity of the Raf-1 catalytic domain is directly upregulated by phosphorylation, following relief of inhibition by the N-terminal regulatory domain upon Ras-GTP binding. Moreover, the presence of serine 621 in the free catalytic fragment is required for full CR3 activation by stimulatory factors, and the continuous presence of 14-3-3 at this site is necessary for retaining activity once the kinase is activated.

Full Text

The Full Text of this article is available as a PDF (184.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aitken A., Howell S., Jones D., Madrazo J., Martin H., Patel Y., Robinson K. Post-translationally modified 14-3-3 isoforms and inhibition of protein kinase C. Mol Cell Biochem. 1995 Aug-Sep;149-150:41–49. doi: 10.1007/BF01076562. [DOI] [PubMed] [Google Scholar]
  2. Avruch J., Zhang X. F., Kyriakis J. M. Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem Sci. 1994 Jul;19(7):279–283. doi: 10.1016/0968-0004(94)90005-1. [DOI] [PubMed] [Google Scholar]
  3. Barnard D., Diaz B., Clawson D., Marshall M. Oncogenes, growth factors and phorbol esters regulate Raf-1 through common mechanisms. Oncogene. 1998 Sep 24;17(12):1539–1547. doi: 10.1038/sj.onc.1202061. [DOI] [PubMed] [Google Scholar]
  4. Bonnefoy-Bérard N., Liu Y. C., von Willebrand M., Sung A., Elly C., Mustelin T., Yoshida H., Ishizaka K., Altman A. Inhibition of phosphatidylinositol 3-kinase activity by association with 14-3-3 proteins in T cells. Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10142–10146. doi: 10.1073/pnas.92.22.10142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Braselmann S., McCormick F. Bcr and Raf form a complex in vivo via 14-3-3 proteins. EMBO J. 1995 Oct 2;14(19):4839–4848. doi: 10.1002/j.1460-2075.1995.tb00165.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Carroll M. P., May W. S. Protein kinase C-mediated serine phosphorylation directly activates Raf-1 in murine hematopoietic cells. J Biol Chem. 1994 Jan 14;269(2):1249–1256. [PubMed] [Google Scholar]
  7. Chu G., Hayakawa H., Berg P. Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acids Res. 1987 Feb 11;15(3):1311–1326. doi: 10.1093/nar/15.3.1311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Conklin D. S., Galaktionov K., Beach D. 14-3-3 proteins associate with cdc25 phosphatases. Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7892–7896. doi: 10.1073/pnas.92.17.7892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cutler R. E., Jr, Morrison D. K. Mammalian Raf-1 is activated by mutations that restore Raf signaling in Drosophila. EMBO J. 1997 Apr 15;16(8):1953–1960. doi: 10.1093/emboj/16.8.1953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Diaz B., Barnard D., Filson A., MacDonald S., King A., Marshall M. Phosphorylation of Raf-1 serine 338-serine 339 is an essential regulatory event for Ras-dependent activation and biological signaling. Mol Cell Biol. 1997 Aug;17(8):4509–4516. doi: 10.1128/mcb.17.8.4509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ellis L., Clauser E., Morgan D. O., Edery M., Roth R. A., Rutter W. J. Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell. 1986 Jun 6;45(5):721–732. doi: 10.1016/0092-8674(86)90786-5. [DOI] [PubMed] [Google Scholar]
  12. Evan G. I., Lewis G. K., Ramsay G., Bishop J. M. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol. 1985 Dec;5(12):3610–3616. doi: 10.1128/mcb.5.12.3610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fabian J. R., Daar I. O., Morrison D. K. Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase. Mol Cell Biol. 1993 Nov;13(11):7170–7179. doi: 10.1128/mcb.13.11.7170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ferrier A. F., Lee M., Anderson W. B., Benvenuto G., Morrison D. K., Lowy D. R., DeClue J. E. Sequential modification of serines 621 and 624 in the Raf-1 carboxyl terminus produces alterations in its electrophoretic mobility. J Biol Chem. 1997 Jan 24;272(4):2136–2142. doi: 10.1074/jbc.272.4.2136. [DOI] [PubMed] [Google Scholar]
  15. Heidecker G., Huleihel M., Cleveland J. L., Kolch W., Beck T. W., Lloyd P., Pawson T., Rapp U. R. Mutational activation of c-raf-1 and definition of the minimal transforming sequence. Mol Cell Biol. 1990 Jun;10(6):2503–2512. doi: 10.1128/mcb.10.6.2503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. King A. J., Sun H., Diaz B., Barnard D., Miao W., Bagrodia S., Marshall M. S. The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338. Nature. 1998 Nov 12;396(6707):180–183. doi: 10.1038/24184. [DOI] [PubMed] [Google Scholar]
  17. Kolch W., Heidecker G., Kochs G., Hummel R., Vahidi H., Mischak H., Finkenzeller G., Marmé D., Rapp U. R. Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature. 1993 Jul 15;364(6434):249–252. doi: 10.1038/364249a0. [DOI] [PubMed] [Google Scholar]
  18. Kyriakis J. M., App H., Zhang X. F., Banerjee P., Brautigan D. L., Rapp U. R., Avruch J. Raf-1 activates MAP kinase-kinase. Nature. 1992 Jul 30;358(6385):417–421. doi: 10.1038/358417a0. [DOI] [PubMed] [Google Scholar]
  19. Li S., Janosch P., Tanji M., Rosenfeld G. C., Waymire J. C., Mischak H., Kolch W., Sedivy J. M. Regulation of Raf-1 kinase activity by the 14-3-3 family of proteins. EMBO J. 1995 Feb 15;14(4):685–696. doi: 10.1002/j.1460-2075.1995.tb07047.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Marais R., Light Y., Mason C., Paterson H., Olson M. F., Marshall C. J. Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science. 1998 Apr 3;280(5360):109–112. doi: 10.1126/science.280.5360.109. [DOI] [PubMed] [Google Scholar]
  21. Marais R., Light Y., Paterson H. F., Marshall C. J. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J. 1995 Jul 3;14(13):3136–3145. doi: 10.1002/j.1460-2075.1995.tb07316.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Marquardt B., Frith D., Stabel S. Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro. Oncogene. 1994 Nov;9(11):3213–3218. [PubMed] [Google Scholar]
  23. Marshall C. J. Signal transduction. Hot lips and phosphorylation of protein kinases. Nature. 1994 Feb 24;367(6465):686–686. doi: 10.1038/367686a0. [DOI] [PubMed] [Google Scholar]
  24. Marshall M. S. Ras target proteins in eukaryotic cells. FASEB J. 1995 Oct;9(13):1311–1318. doi: 10.1096/fasebj.9.13.7557021. [DOI] [PubMed] [Google Scholar]
  25. Mason C. S., Springer C. J., Cooper R. G., Superti-Furga G., Marshall C. J., Marais R. Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation. EMBO J. 1999 Apr 15;18(8):2137–2148. doi: 10.1093/emboj/18.8.2137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Michaud N. R., Fabian J. R., Mathes K. D., Morrison D. K. 14-3-3 is not essential for Raf-1 function: identification of Raf-1 proteins that are biologically activated in a 14-3-3- and Ras-independent manner. Mol Cell Biol. 1995 Jun;15(6):3390–3397. doi: 10.1128/mcb.15.6.3390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Morrison D. K., Heidecker G., Rapp U. R., Copeland T. D. Identification of the major phosphorylation sites of the Raf-1 kinase. J Biol Chem. 1993 Aug 15;268(23):17309–17316. [PubMed] [Google Scholar]
  28. Morrison D. K., Kaplan D. R., Rapp U., Roberts T. M. Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity. Proc Natl Acad Sci U S A. 1988 Dec;85(23):8855–8859. doi: 10.1073/pnas.85.23.8855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Morrison D. K. Mechanisms regulating Raf-1 activity in signal transduction pathways. Mol Reprod Dev. 1995 Dec;42(4):507–514. doi: 10.1002/mrd.1080420420. [DOI] [PubMed] [Google Scholar]
  30. Muslin A. J., Tanner J. W., Allen P. M., Shaw A. S. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell. 1996 Mar 22;84(6):889–897. doi: 10.1016/s0092-8674(00)81067-3. [DOI] [PubMed] [Google Scholar]
  31. Rommel C., Radziwill G., Lovrić J., Noeldeke J., Heinicke T., Jones D., Aitken A., Moelling K. Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1. Oncogene. 1996 Feb 1;12(3):609–619. [PubMed] [Google Scholar]
  32. Roy S., McPherson R. A., Apolloni A., Yan J., Lane A., Clyde-Smith J., Hancock J. F. 14-3-3 facilitates Ras-dependent Raf-1 activation in vitro and in vivo. Mol Cell Biol. 1998 Jul;18(7):3947–3955. doi: 10.1128/mcb.18.7.3947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Schönwasser D. C., Marais R. M., Marshall C. J., Parker P. J. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol Cell Biol. 1998 Feb;18(2):790–798. doi: 10.1128/mcb.18.2.790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Thorson J. A., Yu L. W., Hsu A. L., Shih N. Y., Graves P. R., Tanner J. W., Allen P. M., Piwnica-Worms H., Shaw A. S. 14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity. Mol Cell Biol. 1998 Sep;18(9):5229–5238. doi: 10.1128/mcb.18.9.5229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Tzivion G., Luo Z., Avruch J. A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature. 1998 Jul 2;394(6688):88–92. doi: 10.1038/27938. [DOI] [PubMed] [Google Scholar]
  36. Ueda Y., Hirai S. i., Osada S. i., Suzuki A., Mizuno K., Ohno S. Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J Biol Chem. 1996 Sep 20;271(38):23512–23519. doi: 10.1074/jbc.271.38.23512. [DOI] [PubMed] [Google Scholar]
  37. Vincenz C., Dixit V. M. 14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adapter molecules. J Biol Chem. 1996 Aug 16;271(33):20029–20034. doi: 10.1074/jbc.271.33.20029. [DOI] [PubMed] [Google Scholar]
  38. Xing H., Kornfeld K., Muslin A. J. The protein kinase KSR interacts with 14-3-3 protein and Raf. Curr Biol. 1997 May 1;7(5):294–300. doi: 10.1016/s0960-9822(06)00152-7. [DOI] [PubMed] [Google Scholar]
  39. Zha J., Harada H., Yang E., Jockel J., Korsmeyer S. J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L) Cell. 1996 Nov 15;87(4):619–628. doi: 10.1016/s0092-8674(00)81382-3. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES